Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations
Background: Hemostatic powders offer unique therapeutic advantages over other formulations, including ease of application and rapid distribution over large bleeding surfaces. The efficacy of powder-based hemostats is dependent on device performance, which is rarely investigated independently from ef...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037924003637 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832540396293455872 |
|---|---|
| author | Marianne Stark Allen Y. Wang Brittny Corrigan Henok G. Woldu Samar Azizighannad Gustavo Cipolla Richard Kocharian Hector De Leon |
| author_facet | Marianne Stark Allen Y. Wang Brittny Corrigan Henok G. Woldu Samar Azizighannad Gustavo Cipolla Richard Kocharian Hector De Leon |
| author_sort | Marianne Stark |
| collection | DOAJ |
| description | Background: Hemostatic powders offer unique therapeutic advantages over other formulations, including ease of application and rapid distribution over large bleeding surfaces. The efficacy of powder-based hemostats is dependent on device performance, which is rarely investigated independently from efficacy. Objectives: The current study aimed to compare the hemostatic efficacy of an oxidized regenerated cellulose agent (Surgicel, Ethicon, Inc) and 3 starch-based biopolymers (Arista, Becton Dickinson; PerClot, Baxter International; and 4DryField, PlantTec Medical GmbH) and the performance of their delivery device applicators. Methods: Efficacy was evaluated in a porcine model of bleeding using 2 study designs where the powder was delivered with (experiment 1) and without (experiment 2) device applicators. Device performance (powder expression) was examined in vitro at 3 device positions/angles: 90° (vertical, downward), 45° (slanted, downward), and 180° (horizontal). Results: Surgicel efficacy rate was noninferior (P ≤ .0002) and superior (P ≤ .004) to that of any of the 3 starch-based agents regardless of whether the powder was delivered with their devices (experiment 1) or directly applied onto the bleeding sites (experiment 2). Surgicel required fewer applications (P ≤ .0002) and less powder (P < .0001) to achieve hemostasis. The Surgicel device was the only one that consistently delivered precise amounts of powder over a critical range of applications in the 3 positions tested. Conclusion: The oxidized regenerated cellulose powder was the most efficacious hemostat, and the Surgicel applicator exhibited the highest performance compared with any of the 3 starch-based devices investigated. The current study highlights the relevance of combining high-efficacy powder hemostats with innovative, high-performance applicators to effectively manage bleeding control in surgical settings. |
| format | Article |
| id | doaj-art-70636f10f92449eda3f0ea350c395b52 |
| institution | Kabale University |
| issn | 2475-0379 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Research and Practice in Thrombosis and Haemostasis |
| spelling | doaj-art-70636f10f92449eda3f0ea350c395b522025-02-05T04:32:29ZengElsevierResearch and Practice in Thrombosis and Haemostasis2475-03792025-01-0191102668Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulationsMarianne Stark0Allen Y. Wang1Brittny Corrigan2Henok G. Woldu3Samar Azizighannad4Gustavo Cipolla5Richard Kocharian6Hector De Leon7Preclinical Research, Ethicon, Inc, Raritan, NJ 08869, USAPreclinical Research, Ethicon, Inc, Raritan, NJ 08869, USAPreclinical Research, Ethicon, Inc, Raritan, NJ 08869, USAPreclinical Research, Ethicon, Inc, Raritan, NJ 08869, USAPreclinical Research, Ethicon, Inc, Raritan, NJ 08869, USAPreclinical Research, Ethicon, Inc, Raritan, NJ 08869, USAPreclinical Research, Ethicon, Inc, Raritan, NJ 08869, USACorrespondence Hector De Leon, Ethicon, Inc, 1000 US Highway 202 S, Raritan, NJ 08869, USA.; Preclinical Research, Ethicon, Inc, Raritan, NJ 08869, USABackground: Hemostatic powders offer unique therapeutic advantages over other formulations, including ease of application and rapid distribution over large bleeding surfaces. The efficacy of powder-based hemostats is dependent on device performance, which is rarely investigated independently from efficacy. Objectives: The current study aimed to compare the hemostatic efficacy of an oxidized regenerated cellulose agent (Surgicel, Ethicon, Inc) and 3 starch-based biopolymers (Arista, Becton Dickinson; PerClot, Baxter International; and 4DryField, PlantTec Medical GmbH) and the performance of their delivery device applicators. Methods: Efficacy was evaluated in a porcine model of bleeding using 2 study designs where the powder was delivered with (experiment 1) and without (experiment 2) device applicators. Device performance (powder expression) was examined in vitro at 3 device positions/angles: 90° (vertical, downward), 45° (slanted, downward), and 180° (horizontal). Results: Surgicel efficacy rate was noninferior (P ≤ .0002) and superior (P ≤ .004) to that of any of the 3 starch-based agents regardless of whether the powder was delivered with their devices (experiment 1) or directly applied onto the bleeding sites (experiment 2). Surgicel required fewer applications (P ≤ .0002) and less powder (P < .0001) to achieve hemostasis. The Surgicel device was the only one that consistently delivered precise amounts of powder over a critical range of applications in the 3 positions tested. Conclusion: The oxidized regenerated cellulose powder was the most efficacious hemostat, and the Surgicel applicator exhibited the highest performance compared with any of the 3 starch-based devices investigated. The current study highlights the relevance of combining high-efficacy powder hemostats with innovative, high-performance applicators to effectively manage bleeding control in surgical settings.http://www.sciencedirect.com/science/article/pii/S2475037924003637animal modelhemostasisoxidized regenerated cellulosepolysaccharidesstarch |
| spellingShingle | Marianne Stark Allen Y. Wang Brittny Corrigan Henok G. Woldu Samar Azizighannad Gustavo Cipolla Richard Kocharian Hector De Leon Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations Research and Practice in Thrombosis and Haemostasis animal model hemostasis oxidized regenerated cellulose polysaccharides starch |
| title | Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations |
| title_full | Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations |
| title_fullStr | Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations |
| title_full_unstemmed | Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations |
| title_short | Comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch-based powder formulations |
| title_sort | comparative analyses of the hemostatic efficacy and surgical device performance of powdered oxidized regenerated cellulose and starch based powder formulations |
| topic | animal model hemostasis oxidized regenerated cellulose polysaccharides starch |
| url | http://www.sciencedirect.com/science/article/pii/S2475037924003637 |
| work_keys_str_mv | AT mariannestark comparativeanalysesofthehemostaticefficacyandsurgicaldeviceperformanceofpowderedoxidizedregeneratedcelluloseandstarchbasedpowderformulations AT allenywang comparativeanalysesofthehemostaticefficacyandsurgicaldeviceperformanceofpowderedoxidizedregeneratedcelluloseandstarchbasedpowderformulations AT brittnycorrigan comparativeanalysesofthehemostaticefficacyandsurgicaldeviceperformanceofpowderedoxidizedregeneratedcelluloseandstarchbasedpowderformulations AT henokgwoldu comparativeanalysesofthehemostaticefficacyandsurgicaldeviceperformanceofpowderedoxidizedregeneratedcelluloseandstarchbasedpowderformulations AT samarazizighannad comparativeanalysesofthehemostaticefficacyandsurgicaldeviceperformanceofpowderedoxidizedregeneratedcelluloseandstarchbasedpowderformulations AT gustavocipolla comparativeanalysesofthehemostaticefficacyandsurgicaldeviceperformanceofpowderedoxidizedregeneratedcelluloseandstarchbasedpowderformulations AT richardkocharian comparativeanalysesofthehemostaticefficacyandsurgicaldeviceperformanceofpowderedoxidizedregeneratedcelluloseandstarchbasedpowderformulations AT hectordeleon comparativeanalysesofthehemostaticefficacyandsurgicaldeviceperformanceofpowderedoxidizedregeneratedcelluloseandstarchbasedpowderformulations |